nivolumab,ipilimumab
ono Pharmaceuticals,BMS,ono Pharmaceuticals,BMS
['colorectal', 'breast', 'rectal', 'natera', '$ntra ']
$ntra natera presents new colorectal and breast cancer data at esmo 2022, highlighting signatera's ability to inform treatment decisions in the adjuvant and neoadjuvant settings 